http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170088695-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d98762490c9bfd1551fefe55f49ea2c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bd26c380ad709cb8f9a969bed470b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520a2bfde707ace7f4580c646bde3ea4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd78730971da138ea88454dc3770a3c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7721e72832feb1ab05d24a2f45e4f8 |
| publicationDate | 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170088695-A |
| titleOfInvention | Phenanthroindolizidine or phenanthroquinolizidine alkaloid derivatives, optical isomer thereof, or pharmaceutically acceptable salts thereof, and a anticancer composition containing the same as an active ingredient |
| abstract | The present invention relates to phenanthroindolizidine or phenanthroquinolizidine alkaloid derivatives, optical isomers thereof or pharmaceutically allowable salts thereof, and a pharmaceutical composition for preventing cancer or inhibiting metastasis of cancer cells comprising the same as an active ingredient. The phenanthroindolizidine or phenanthroquinolizidine alkaloid derivatives are effective in inhibiting growth and metastasis of cancer cells, thereby being used as an anticancer composition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022045520-A1 |
| priorityDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.